The sequencing of MLH1 (mutL homolog 1), MSH2 (mutS homolog 2), and MSH6 (mutS homolog 6) genes is recommended for surveillance and preventive treatment for the hereditary non-polypoid colon cancer or Lynch’s syndrome, which involves malignancies in other organs as well. This evidence concerns the gene MLH1 and Lynch syndrome.